OUP (Osage University Partners)

Osage University Partners is a venture capital firm focused on investing in startups that are commercializing university technologies. Osage partners with research universities to invest in their innovative startups shareing its investment profit with partner institutions. The firm invests in software, hardware, and life science companies at all stages of company development. To date, it has partnered with over 80 universities, including 36 of the top 50 U.S. institutions by research expenditures, and has invested in over 50 of their spinouts.

OUP (Osage University Partners), established in 2009 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Seed, Private Equity investments across Biotechnology, Pharmaceutical, Diabetes, Financial Services, Venture Capital, Finance, Health Care, Asset Management, Wealth Management, Life Science. The organization boasts a portfolio of 214 investments, with an average round size of $37.0M and 56 successful exits. Their recent investments include Avid Radiopharmaceuticals, Safeguard Scientifics, AllianceBernstein, BioAdvance, Alta Partners. The highest investment round they participated in was $947.3B. Among their most notable exits are Avid Radiopharmaceuticals and Safeguard Scientifics. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.